🦴 Bone Density & Fracture Risk

What this panel can settle, and by what logic

Eight markers, and none of them is a bone measurement. What this combination settles is why a density scan is falling, and the four markers that do that work are the four a mineral panel usually leaves out.

1. Estradiol, Sensitive (LC/MS-MS) and Total Testosterone beside the mineral chemistry, because sex steroid loss is the largest single driver and it is the one with a treatment. The cleanest evidence is a drug trial rather than an observational one: 2 years of an aromatase inhibitor against placebo was designed to measure exactly what removing estrogen does to bone density and to bone biomarkers together Lønning 2005. A postmenopausal estradiol under 5 pg/mL with a rising Osteocalcin is that mechanism running in an untreated person.
2. TSH (Thyroid-Stimulating Hormone) costs $9 and finds an accelerant nobody is looking for. A suppressed TSH on thyroid replacement is over-treatment, and it thins bone silently for years. This is the cheapest correctable finding on the list and the only one that is usually iatrogenic.
3. Magnesium, RBC explains the vitamin D that will not budge. Magnesium and vitamin D status track together in adults with a high prevalence of deficiency Zittermann 2024, and the practical consequence is specific: replacing Vitamin D (25-Hydroxy) in a magnesium-depleted person often moves the number less than expected.
4. Parathyroid Hormone & Calcium read as a pair turns one result into a differential. A raised parathyroid hormone with a normal calcium is not a diagnosis and it is not automatically vitamin D deficiency: kidney function, magnesium status, malabsorption and thiazide use all produce it, and they are worked through in an order Shaker 2023. The Comprehensive Metabolic Panel (CMP) on this list carries the creatinine and albumin that start that work.

Osteocalcin answers a separate question from all of them: whether bone is being rebuilt quickly or slowly at the moment of the draw, which is a rate, and no scan reports a rate Bhattoa 2025.

What it cannot settle, and what would

It cannot measure bone density, and a normal panel does not mean normal bone. Density is measured by DEXA and osteoporosis is defined by a T-score, so no arrangement of calcium, parathyroid hormone, vitamin D, estradiol and turnover markers can produce or exclude the diagnosis Bhattoa 2025. Someone can hold a flawless result on all eight of these and a T-score of −2.8 on the same day. If you have had a fragility fracture, lost height, taken oral steroids for months, or gone a year without a period, the scan is the purchase and this panel is the follow-up to it.

Osteocalcin gives you a direction, not a position. Bone turnover markers are placed in monitoring and in fracture-risk assessment, not in diagnosis Bhattoa 2025. A high value says remodeling is running fast, which is compatible with rapid loss, with healing after a fracture, and with the first months of a treatment that is working. Three different stories, one number.

It does not contain the second half of a fracture risk. Fracture risk calculators run on age, weight, prior fracture, parental hip fracture, smoking, steroid exposure and alcohol. None of those is a blood test, and a panel cannot supply any of them.

And it carries no test for celiac disease or myeloma, which are the two secondary causes most likely to be missed in somebody young with unexplained bone loss. Tissue transglutaminase antibodies and a serum protein electrophoresis are the next $120, and neither is on this list Shaker 2023.

Draw conditions that decide whether the money is wasted

Two of these markers are ruined by a normal morning. The result still arrives looking like a result, which is what makes this the expensive mistake.

1. Fasted, before 10am, and the same way every time. Turnover markers carry a marked circadian rhythm and are suppressed by eating, which is why standardized fasting morning collection is specified rather than recommended Bhattoa 2025. A Osteocalcin drawn after lunch cannot be compared with the fasted one you will pay for in 3 months, which deletes the only use the marker has.
2. No calcium or vitamin D supplement on the morning of the draw. A dose taken with breakfast raises serum calcium for hours and pushes parathyroid hormone down with it, so the Parathyroid Hormone & Calcium pair reports the supplement instead of the gland Gong 2023.
3. No biotin for 3 days. Parathyroid hormone, 25-hydroxyvitamin D, TSH (Thyroid-Stimulating Hormone) and estradiol are commonly run on streptavidin-based platforms, and interference runs in opposite directions depending on the assay format, so a single supplement can move four of these eight numbers and move two of them the wrong way Li 2020. Hair and nail products carry 5,000 to 10,000 mcg, which is thousands of times the dietary intake.
4. Insist on the sensitive estradiol, not the standard one. At postmenopausal and male concentrations the routine immunoassay is not the recommended method, and the position statements on measuring sex steroids say so explicitly Casals 2023. This panel already specifies the LC-MS/MS version; the failure mode is a cheaper substitution somewhere else producing a number that reads normal because the assay cannot see that low.

How you would know it answered your question, and what each pattern means next

Bone runs on quarters, not weeks. Four patterns and the interval each one earns.

• Low Vitamin D (25-Hydroxy) with parathyroid hormone high in its interval: replace, and recheck both at 12 weeks. Parathyroid hormone settles as vitamin D crosses roughly 22 ng/mL Gong 2023, and a 4-week recheck is reading the supplement rather than the response.
• Raised parathyroid hormone with a normal calcium and a normal vitamin D: do not add more vitamin D. Work the list Shaker 2023 — creatinine on the Comprehensive Metabolic Panel (CMP), Magnesium, RBC, celiac serology, and the medication list — because each of those has a different answer and only one of them is a supplement.
• Low Estradiol, Sensitive (LC/MS-MS) or low Total Testosterone with a high Osteocalcin: the loss is hormonal and it is active now. This is the pattern that belongs in a clinic this month rather than in another panel, because the treatment decision is a hormone decision Lønning 2005.
• Everything in range: the panel did its job and the answer is that the correctable causes are absent. Book the DEXA. If treatment starts after it, a repeat Osteocalcin at 3 months is the earliest evidence you can buy that the treatment is doing anything Bhattoa 2025 — and the reason it is 3 months rather than 6 is that a remodeling cycle turns over on roughly that timescale.

Sources read for these sections

• Bhattoa HP, et al. Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Osteoporosis International 2025 · PMID 40152990
• Shaker JL, Wermers RA. The Eucalcemic Patient With Elevated Parathyroid Hormone Levels. Journal of the Endocrine Society 2023 · PMID 36793479
• Gong M, et al. Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone. Journal of Endocrinological Investigation 2023 · PMID 36920734
• Zittermann A, et al. Association between magnesium and vitamin D status in adults with high prevalence of vitamin D deficiency and insufficiency. European Journal of Nutrition 2024 · PMID 39680162
• Lønning PE, Geisler J, Krag LE. Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer.. J Clin Oncol 2005 · PMID 15983390
• Casals G, et al. Recommendations for the measurement of sexual steroids in clinical practice. A position statement of SEQCML/SEEN/SEEP. Advances in Laboratory Medicine 2023 · PMID 37359897
• Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med 2020 · PMID 32445355